|1.||Akgul, Ozlem: 1 article (12/2007)|
|2.||Erol, Kevser: 1 article (12/2007)|
|3.||Pabuccuoglu, Varol: 1 article (12/2007)|
|4.||Sultan Kilic, Fatma: 1 article (12/2007)|
|5.||Gupta, R C: 1 article (01/2005)|
|6.||Bittner, S: 1 article (01/2005)|
|7.||Win, T: 1 article (01/2005)|
|8.||Usifoh, C O: 1 article (10/2001)|
|9.||Scriba, G K: 1 article (10/2001)|
|10.||Lambert, D M: 1 article (10/2001)|
|1.||Partial Epilepsies (Epilepsy, Partial)
08/01/1990 - "A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy."
08/01/1990 - "In partial epilepsy of 7 the seizure frequency was reduced by 27% during valproate (p less than 0.05), compared with placebo, while no improvement was found during taltrimide. "
01/01/1986 - "The anticonvulsive effect of taltrimide observed in animal experiments could not be confirmed in this study; in contrast, the seizures increased statistically significantly during taltrimide treatment. "
01/01/1986 - "The frequency of seizures increased statistically significantly during the trial with increasing dose of taltrimide and decreased again in the withdrawal phase of the trial. "
12/01/2007 - "The anticonvulsant activity of the title compounds was determined against maximal electroshock seizure in mice at a dose level of 100 mg/kg. The preliminary screening results indicated that the exchange of the N-isopropyl moiety for an N-phenyl ring in the taltrimide molecule abolished the anticonvulsant activity. "
01/01/1986 - "Of six dropouts, one had status epilepticus, and in two patients increased number or severity of seizures necessitated withdrawal of taltrimide. "
08/01/1990 - "In 6 with primary generalized epilepsy, the number of seizures was reduced by 49% during taltrimide and by 38% during valproate, but neither effect was significant, compared with placebo. "
03/01/1987 - "Taltrimide is a lipophilic taurine derivative with definitive anticonvulsive effects in experimental epilepsy models. "
01/01/1986 - "The antiepileptic effect, effects on EEG, and tolerability of taltrimide, a new taurine derivative, were studied in this open clinical trial in 27 patients with severe epilepsy resistant to conventional drugs. "
08/01/1990 - "Taltrimide was compared with valproate and placebo in 17 patients with intractable epilepsy being on carbamazepine monotherapy. "
|4.||Status Epilepticus (Complex Partial Status Epilepticus)
|1.||Valproic Acid (Valproate, Semisodium)
|3.||Glycine (Aminoacetic Acid)
|4.||gamma-Aminobutyric Acid (GABA)
|8.||1- (2- chloroethyl)- 3- (2- (dimethylaminosulfonyl)ethyl)- 1- nitrosourea (tauromustine)